Avidity Biosciences
RNA
#1858
Rank
A$15.77 B
Marketcap
A$104.68
Share price
0.23%
Change (1 day)
101.24%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: A$15.77 Billion

As of February 2026 Avidity Biosciences has a market cap of A$15.77 Billion. This makes Avidity Biosciences the world's 1858th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.77 B-2.79%
2025A$16.22 B180.94%
2024A$5.77 B449.14%
2023A$1.05 B-51.47%
2022A$2.16 B40.95%
2021A$1.53 B23.46%
2020A$1.24 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Avidity Biosciences was reported to be:

A$15.73 Billion
by Nasdaq info icon info icon
A$15.73 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$218.14 B 1,283.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$152.60 B 867.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$3.12 B-80.19%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.65 B-45.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.20 B-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.18 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.73 B-0.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.42 B-71.96%๐Ÿ‡บ๐Ÿ‡ธ USA